FDA may be ready to add a new warning to fluoroquinolone labels related to potentially permanent multi-organ system complications.
It is part of a larger question for the agency as it continues to evaluate the antibiotic class: Are additional...
Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?